AstraZeneca has announced that the pharmaceutical giant is to switch its fleet of 16,000 vehicles to electric to limit the health impacts of air pollution across the globe.

The announcement makes the UK headquartered company the first pharmaceutical company to join the EV100 initiative by The Climate Group. Katarina Ageborg, EVP, sustainability and chief compliance officer, AstraZeneca, said: “Recognising the link between a healthy environment and human health, we believe that by investing in electric vehicles and emissions-reduction initiatives, we can help reduce the burden of respiratory diseases and other air pollution-related conditions.”

AstraZeneca is the 50th business to join the EV100 initiative overall, and companies representing $900bn in annual turnover and 2.8 million employees in total are now committed to electrifying transport through the initiative.

AstraZeneca is also a member of The Climate Group’s RE100 initiative, in partnership with CDP, where it is committed to sourcing 100 per cent renewable electricity by 2020 in Europe and the US and for its global operations by 2025.

Share Story: